Internal Limiting Membrane Peeling for Large Macular Holes

Comparison of the Success Rate of a Procedure With Peeling of Limiting the Intern of the Retina Versus a Traditional Procedure Without Peeling of Limiting, at Patients Presenting a Macular Hole.

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at third postoperative month is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.

Study Overview

• Status: Completed
• Conditions: Macular Hole
• Intervention / Treatment: Procedure: With Peeling of Limiting the Intern of the Retina; Procedure: Internal limiting membrane peeling

Detailed Description

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at three postoperative months is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Secondary objectives: - Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. - Gain of ETDRS visual acuity in the third postoperative month.- Progression of cataract - Frequency of the complications.

Number of subjects and duration of the study: 80 patients older than 18 yo , presenting a macular hole > 400 µm, divided into two parallel groups will be included and followed up 3 months. The estimated total duration of the study is 27 months.

Statistical analysis: The percentages of success in the 2 groups will be compared by a Chi ² or Fisher exact test. The test Q of COCHRAN will be used to take into account the ordered character of the categories.

Intermediate Analysis: An intermediate analysis is envisaged. The procedure of adjustment of the risk of Lan and DeMets will be used.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.

• Study Type: Interventional
• Enrollment (Actual): 80
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Paris, France, 75010
    • Service d'Ophtalmolgie de l'Hôpital Lariboisière

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Age equal to or higher than 18 years
• Patient presenting a TM idiopathic of stage 2, 3 or 4
• Macular hole > 400 µm in diameter
• Patient having been informed of the objectives and constraints of the study and having signed an informed consent

Exclusion Criteria:

• Patient age < 18 years.
• Patient having a strong myopia of the operated eye: correction carried or optimal >6 dioptres
• Patient MONOPHTHALMIA.
• Patient pseudophakia presenting an "insufficient" plan capsular CRYTALLINE.
• Patient presenting a cataract making impossible a good visualization of the bottom of eye.
• Patient presenting an important opacification capsular.
• Patient presenting an associated ocular pathology being able to interfere with the operation.
• Patient presenting a TM already operated of the eye to include

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: 1; With Peeling of Limiting the Intern of the Retina	Procedure: With Peeling of Limiting the Intern of the Retina; With Peeling of Limiting the Intern of the Retina
Active Comparator: 2; Traditional Procedure Without Peeling of Limiting	Procedure: Internal limiting membrane peeling; Traditional Procedure Without Peeling of Limiting; Other Names: Traditional Procedure Without Peeling of Limiting

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
percentage of success (anatomical closing, confirmed by OCT) at third postoperative month, in both groups	at 3 months

Secondary Outcome Measures

Outcome Measure	Time Frame
Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI.	at 3 months
Gain of ETDRS visual acuity in the third postoperative month	at 3 months
Progression of cataract	at 3 months
Frequency of the complications.	at 3 months

Collaborators and Investigators

• Sponsor: Assistance Publique - Hôpitaux de Paris
• Investigators: Principal Investigator: Ramin TADAYONI, MD, Assistance Publique - Hôpitaux de Paris

Study record dates

Study Major Dates

• Study Start: January 1, 2005
• Primary Completion (Actual): May 1, 2008
• Study Completion (Actual): May 1, 2008

Study Registration Dates

• First Submitted: September 13, 2005
• First Submitted That Met QC Criteria: September 13, 2005
• First Posted (Estimate): September 19, 2005

Study Record Updates

• Last Update Posted (Estimate): July 18, 2008
• Last Update Submitted That Met QC Criteria: July 16, 2008
• Last Verified: July 1, 2007

More Information

Terms related to this study

• Keywords: surgery; retina; internal limiting membrane; Macular hole
• Additional Relevant MeSH Terms: Eye Diseases; Retinal Diseases; Retinal Perforations
• Other Study ID Numbers: P040604; PS040604